CART-PSMA Cells for Advanced Prostate Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chinese PLA General Hospital, Beijing, China
Contact: Study coordinator (Jay Zhang, MD/PhD)
Contact: Principal Investigator (Xu Zhang, MD/PhD)
Haixing Mai, MD/PhD (Sub-investigator)
Yu Gao, MD/PhD (Sub-investigator)

Study leads

Jay Zhang
Study Director
Nova Therapeutics LLC

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

Prostate Cancer · Prostate Cancer (Diagnosis) · High-risk Prostate Cancer

Abroad (travel likely)RecruitingPHASE1

San Francisco, United States

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Prostate Cancer · Metabolic Syndrome · Obesity

Abroad (travel likely)RecruitingEARLY_PHASE1

London, Canada

Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI

Prostate Cancer Patients Treated by Radiotherapy

Abroad (travel likely)RecruitingPHASE2

Cairo, Egypt · Shibīn al Kawm, Egypt

A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France

Prostatic Neoplasms · Metastatic Hormone-sensitive Prostate Cancer

Abroad (travel likely)Recruiting

Caen, France